BW-723C86
BW-723C86 je lek izveden iz triptamina koji deluje kao agonist 5-HT2B receptora. On pokazuje anksiolitičke efekte u životinjskim studijama,[1][2] a upotrebljavan je i za istraživanje funkcije 5-HT2B receptora u nizu drugih tkiva.[3][4][5]
IUPAC ime | |
---|---|
5-((thiophen-2-yl)methoxy)-α-methyltryptamine | |
Identifikatori | |
CAS broj | 160521-72-2 |
PubChem | CID 5311036 |
Hemijski podaci | |
Formula | C16H18N2OS |
Molarna masa | 286.391 g/mol |
|
Reference uredi
- ^ Kennett, GA; Bright, F; Trail, B; Baxter, GS; Blackburn, TP (1996). „Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety”. British journal of pharmacology. 117 (7): 1443—8. PMC 1909458 . PMID 8730737.
- ^ Kennett, G; Trail, B; Bright, F (1998). „Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated”. Neuropharmacology. 37 (12): 1603. PMID 9886683. doi:10.1016/S0028-3908(98)00115-4.
- ^ Knowles, ID; Ramage, AG (januar 2000). „Evidence that activation of central 5-HT2B receptors causes renal sympathoexcitation in anaesthetized rats”. British Journal of Pharmacology. 129 (1): 177—83. PMC 1621132 . PMID 10694218. doi:10.1038/sj.bjp.0703011.
- ^ Günther, S; Maroteaux, L; Schwarzacher, SW (avgust 2006). „Endogenous 5-HT2B receptor activation regulates neonatal respiratory activity in vitro”. Journal of Neurobiology. 66 (9): 949—61. PMID 16758492. doi:10.1002/neu.20253.
- ^ Ryan, BK; Anwyl, R; Rowan, MJ (avgust 2008). „5-HT2 receptor-mediated reversal of the inhibition of hippocampal long-term potentiation by acute inescapable stress”. Neuropharmacology. 55 (2): 175—82. PMID 18538800. doi:10.1016/j.neuropharm.2008.05.006.
Spoljašnje veze uredi
Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |